OpenAI is continuing its push into healthcare by investing in Merge Labs, a brain computer interface startup co-founded by its CEO, Sam Altman. Merge Labs is a competitor in the brain computer ...
Sam Altman’s new brain-computer interface lab pursues non-invasive, AI-native neural hardware that rivals Neuralink and stirs governance debate.
OpenAI did not disclose the amount of its investment, a portion of the $252 million seed round that also came from investors ...
Morning Overview on MSN
Light-based brain implant sends data straight into neural tissue
Light is quietly becoming the new language of brain technology. Instead of thick wires and skull-penetrating electrodes, a new generation of implants uses tiny LEDs and optical sensors to send ...
An important milestone has been achieved in brain-computer interface (BCI) technology. A new peer-reviewed study published in Nature Biomedical Engineering shows how a high-performance brain-computer ...
Brain–computer interfaces have advanced rapidly, driven by medical needs and private investment. Devices can now translate neural signals into digital commands. Initially designed to restore movement ...
The Cerelog ESP-EEG is an 8-channel, low-cost brain computer interface (BCI) circuit board built around the ESP32 MCU and designed for EEG data acquisition. The board supports 8-channel, 24-bit EEG ...
Brain–computer interfaces are beginning to truly "understand" Chinese. The INSIDE Institute for NeuroAI, in collaboration with Huashan Hospital affiliated with Fudan University, the National Center ...
OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...
BOSTON--(BUSINESS WIRE)--Neurable, the leader in noninvasive brain-computer interface (BCI) technology designed for everyday life, today announced it has closed a $35 million Series A round to ...
Li Xue (left) and Zhao Zhengtou (center), co-founders of StairMed, conduct preoperative planning with Lu Junfeng at Huashan Hospital, Fudan University. The team was preparing for a clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback